Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Volunteers on Clinical Trials Utilising Machine-learning and Bioimpedance Vector Analysis

NCT04873258 is registered in ClinicalTrials.gov with Richmond Research Institute as lead sponsor.

NCT NCT04873258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04873258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Volunteers on Clinical Trials Utilising Machine-learning and Bioimpedance Vector Analysis
Lead sponsor
Richmond Research Institute
Phase
Observational
Overall status
Recruiting
Start date
September 27, 2019
Completion date
December 31, 2027
Enrollment
2,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fatty liver, healthy, masld, masld - metabolic dysfunction-associated steatotic liver disease, obesity and obesity-related medical conditions